Epicardial adiposity in children with obesity and metabolic syndrome

Erdal Eren1, Bulent Koca2, Mehmet Ture3

  • 1Pediatric Endocrinology Division.

Insights

Obese children show increased epicardial adipose tissue thickness and cardiac changes. These findings highlight the early cardiovascular impact of pediatric obesity, even without metabolic syndrome.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Health
  • Metabolic Syndrome Research

Background:

  • Obesity is a significant risk factor for atherosclerosis and subsequent cardiac diseases.
  • Early detection of cardiac changes in obese children is crucial for preventative strategies.

Purpose of the Study:

  • To determine epicardial adipose tissue thickness in obese children.
  • To identify factors related to epicardial adipose tissue thickness in this population.

Main Methods:

  • A study involving 94 children, categorized into obesity with metabolic syndrome (MS), obesity without MS, and control groups.
  • Evaluation of auxological values, metabolic markers (glucose, insulin, ALT), lipid profiles, and high-sensitivity C-reactive protein.
  • Echocardiography used to measure epicardial adipose tissue thickness, interventricular septum thickness, and left ventricular mass.

Main Results:

  • Obese children exhibited significantly higher weight, BMI, waist circumference, insulin, alanine transaminase, and hs-CRP levels compared to controls.
  • Epicardial adipose tissue thickness was significantly greater in both obese groups (0.64±0.23 cm with MS; 0.60±0.20 cm without MS) versus controls (0.27±0.12 cm).
  • Interventricular septum thickness and left ventricular mass were significantly elevated in obese children without MS.

Conclusions:

  • Pediatric obesity exerts unfavorable effects on the heart, beginning in adolescence.
  • Increased epicardial adipose tissue is a key indicator of cardiac risk in obese children.
  • Cardiac structural changes are evident in obese children, underscoring the need for early intervention.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Hypodermis01:02

Hypodermis

The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
8.7K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.0K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
419